Earnings History Data for Adaptive Biotechnologies Corporation (ADPT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation is a commercial-stage biotech company. It develops and commercializes immune-driven clinical products to transform the diagnosis and treatment of disease. The company's product pipeline includes immunoSEQ, clonoSEQ and cellular therapy which are in clinical stage. Adaptive Biotechnologies Corporation is based in Seattle, Washington.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-02-2024	AH		ADPT	Adaptive Biotechnologies Corporation	567.51	-0.30	-0.27	-0.28	Adaptive Biotechnologies GAAP EPS of -$0.48 misses by $0.15, revenue of $45.78M misses by $2.68M [2/14/2024 4:21 PM]	3.96	0.02 (0.63%)	3.70	-0.24 (-6.09%)	2.61 - 10.38	4,927,615	1,210,000	8,712
Adaptive Biotechnologies GAAP EPS of -$0.48 misses by $0.15, revenue of $45.78M misses by $2.68M [2/14/2024 4:21 PM]
09-11-2023	AH		ADPT	Adaptive Biotechnologies Corporation	697.19	-0.35	-0.32	-0.32	Adaptive Biotechnologies GAAP EPS of -$0.35 misses by $0.01, revenue of $37.92M misses by $5.04M [11/9/2023 4:32 PM]	3.52	-0.77 (-17.95%)	3.82	-0.47 (-10.96%)	2.61 - 10.79	5,846,382	1,630,000	12,889
Adaptive Biotechnologies GAAP EPS of -$0.35 misses by $0.01, revenue of $37.92M misses by $5.04M [11/9/2023 4:32 PM]
02-08-2023	AH		ADPT	Adaptive Biotechnologies Corporation	1,220	-0.33	-0.33	-0.37	Adaptive Biotechnologies GAAP EPS of -$0.33 beats by $0.01, revenue of $48.9M beats by $4.01M [8/2/2023 4:45 PM]	7.00	-0.96 (-12.00%)	7.64	-0.32 (-4.02%)	5.96 - 13.21	2,425,164	780,000	12,429
Adaptive Biotechnologies GAAP EPS of -$0.33 beats by $0.01, revenue of $48.9M beats by $4.01M [8/2/2023 4:45 PM]
03-05-2023	AH	4:05 PM ET (May 3)	ADPT	Adaptive Biotechnologies Corporation	1,050	-0.40	-0.34	-0.44	Adaptive Biotechnologies GAAP EPS of $0.40 beats by $0.78, revenue of $37.6M beats by $0.69M [5/3/2023 5:12 PM]	6.42	-1.08 (-14.33%)	7.50	0.0 (0.00%)	5.95 - 13.21	1,079,463	670,000	27,613
Adaptive Biotechnologies GAAP EPS of $0.40 beats by $0.78, revenue of $37.6M beats by $0.69M [5/3/2023 5:12 PM]
14-02-2023	AH	4:05 PM ET (Feb 14)	ADPT	Adaptive Biotechnologies	1,257	-0.28	-0.37	0.00	Adaptive Biotechnologies GAAP EPS of -$0.28 beats by $0.06, revenue of $55.2M beats by $0.64M [2/14/2023 4:13 PM]	10.00	1.32 (15.21%)	9.70	1.02 (11.75%)	5.95 - 15.67	3,529,314	950,000	1,492
Adaptive Biotechnologies GAAP EPS of -$0.28 beats by $0.06, revenue of $55.2M beats by $0.64M [2/14/2023 4:13 PM]
03-11-2022	AH	4:05 PM ET (Nov 3)	ADPT	Adaptive Biotechnologies Corporation	1,200	-0.32	-0.37	-0.40	Adaptive Biotechnologies GAAP EPS of -$0.32 beats by $0.06, revenue of $47.8M misses by $0.61M; narrows outlook [11/3/2022 4:31 PM]	8.89	1.11 (14.30%)	7.78	0.0 (0.00%)	5.95 - 37.55	1,557,663	1,060,000	18,112
Adaptive Biotechnologies GAAP EPS of -$0.32 beats by $0.06, revenue of $47.8M misses by $0.61M; narrows outlook [11/3/2022 4:31 PM] Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results [Nov-03-22 04:05PM] Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Lags Revenue Estimates [Nov-03-22 06:35PM]
03-08-2022	AH	4:05 PM ET (Aug 3)	ADPT	Adaptive Biotechnologies Corporation	1,240	-0.37	-0.40	-0.35	Adaptive Biotechnologies GAAP EPS of -$0.37 beats by $0.05, revenue of $43.7M beats by $1.89M [8/3/2022 4:25 PM]	11.50	1.61 (16.28%)	10.18	0.29 (2.93%)	5.96 - 40.00	1,975,381	1,180,000	8,848
Adaptive Biotechnologies GAAP EPS of -$0.37 beats by $0.05, revenue of $43.7M beats by $1.89M [8/3/2022 4:25 PM] Adaptive Biotechnologies stock rises as Q2 revenue grows on back of MRD business, reaffirms outlook [8/4/2022 7:17 AM] Is a Surprise Coming for Adaptive Biotechnologies (ADPT) This Earnings Season? [Aug-02-22 10:07AM] Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results [Aug-03-22 04:05PM] Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates [Aug-03-22 05:35PM] Adaptive Biotechnologies Corporation (ADPT) Q2 2022 Earnings Call Transcript [Aug-04-22 12:00AM]
04-05-2022	AH	4:05 PM ET (May 4)	ADPT	Adaptive Biotechnologies	1,173	-0.44	-0.43	0.00	Adaptive Biotechnologies GAAP EPS of -$0.44 in-line, revenue of $38.6M beats by $0.89M [5/4/2022 4:45 PM]	8.84	-0.41 (-4.43%)	8.80	-0.45 (-4.86%)	7.98 - 43.40	1,754,233	1,330,639	2,805
Adaptive Biotechnologies GAAP EPS of -$0.44 in-line, revenue of $38.6M beats by $0.89M [5/4/2022 4:45 PM] Is Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Trading At A 50% Discount? [May-04-22 09:59AM] Adaptive Biotechnologies Reports First Quarter 2022 Financial Results [May-04-22 04:05PM] Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Lags Revenue Estimates [May-04-22 06:35PM] Adaptive Biotechnologies Corporation (ADPT) Q1 2022 Earnings Call Transcript [May-04-22 10:30PM]
15-02-2022	AH	4:05 PM ET (Feb 15)	ADPT	Adaptive Biotechnologies Corporation	2,170	-0.43	-0.43	-0.33	Adaptive Biotechnologies GAAP EPS of -$0.43 beats by $0.02, revenue of $37.9M beats by $1.05M [2/15/2022 4:18 PM]	15.44	0.75 (5.11%)	15.00	0.31 (2.11%)	13.58 - 65.72	1,585,132	1,250,000	88,217
Adaptive Biotechnologies GAAP EPS of -$0.43 beats by $0.02, revenue of $37.9M beats by $1.05M [2/15/2022 4:18 PM] Billionaire Richard Chilton is Dumping These 10 Stocks [Feb-15-22 04:09PM] Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2021 Financial Results [Feb-15-22 04:05PM] Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Tops Revenue Estimates [Feb-15-22 05:55PM] Adaptive Biotechnologies Corporation (ADPT) Q4 2021 Earnings Call Transcript [Feb-15-22 07:30PM]
03-11-2021	AH	4:05 PM ET (Nov 3)	ADPT	Adaptive Biotechnologies Corporation	4,970	-0.40	-0.42	-0.27	Adaptive Biotechnologies EPS beats by $0.03, beats on revenue [11/3/2021 4:09 PM]	36.85	1.81 (5.15%)	35.10	0.06 (0.17%)	29.73 - 71.25	790,320	440,000	830
Adaptive Biotechnologies EPS beats by $0.03, beats on revenue [11/3/2021 4:09 PM] Adaptive Biotechnologies Reports Third Quarter 2021 Financial Results [Nov-03-21 04:05PM] Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Tops Revenue Estimates [Nov-03-21 05:45PM] Adaptive Biotechnologies Corporation (ADPT) Q3 2021 Earnings Call Transcript [Nov-04-21 03:01AM] Adaptive Reuse Apartment Conversions Hit a New Record [Nov-04-21 08:00AM]
04-08-2021	AH	4:05 PM ET (Aug 4)	ADPT	Adaptive Biotechnologies Corporation	5,160	-0.35	-0.43	-0.26	Adaptive Biotechnologies EPS beats by $0.09, beats on revenue [8/4/2021 4:28 PM]	37.59	0.23 (0.62%)	38.00	0.64 (1.71%)	30.41 - 71.25	929,800	440,000	420
Adaptive Biotechnologies EPS beats by $0.09, beats on revenue [8/4/2021 4:28 PM] Adaptive Biotechnologies names Nitin Sood chief commercial officer [8/4/2021 4:54 PM] Adaptive Biotechnologies Reports Second Quarter 2021 Financial Results [Aug-04-21 04:05PM] Adaptive Biotechnologies Appoints Nitin Sood as Chief Commercial Officer [Aug-04-21 04:15PM] Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates [Aug-04-21 06:25PM] Adaptive Biotechnologies Corporation (ADPT) Q2 2021 Earnings Call Transcript [Aug-05-21 09:01AM]
05-05-2021	AH	4:05 PM ET (May 5)	ADPT	Adaptive Biotechnologies Corporation	5,820	-0.29	-0.41	-0.25	Adaptive Biotechnologies EPS beats by $0.12, beats on revenue [5/5/2021 4:23 PM]	36.65	1.19 (3.36%)	35.30	-0.16 (-0.45%)	33.25 - 71.25	1,122,505	770,000	1,137
Adaptive Biotechnologies Reports First Quarter 2021 Financial Results [May-05-21 04:05PM] Adaptive Biotechnologies Corporation (ADPT) Q1 2021 Earnings Call Transcript [May-06-21 03:01AM] Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates [May-05-21 07:15PM]
24-02-2021	AH	4:10 PM ET (Feb 24)	ADPT	Adaptive Biotechnologies Corporation	7,760	-0.33	-0.30	-0.17	Adaptive Biotechnologies EPS misses by $0.04, beats on revenue [2/24/2021 4:35 PM]	55.12	-3.27 (-5.60%)	56.50	-1.89 (-3.24%)	15.19 - 71.25	1,518,770	617,659	437
Adaptive Biotechnologies EPS misses by $0.04, beats on revenue [2/24/2021 4:35 PM] Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2020 Financial Results [Feb-24-21 04:05PM]
10-11-2020	AH	4:05 PM ET (Nov 10)	ADPT	Adaptive Biotechnologies Corporation	6,920	-0.27	-0.28	-0.11	Adaptive Biotechnologies EPS beats by $0.02, beats on revenue [11/10/2020 4:20 PM]	51.78	4.72 (10.02%)	50.00	2.93 (6.22%)	15.19 - 54.20	1,048,515	561,249	4,137

10-08-2020	AH	4:00 PM ET (Aug 10)	ADPT	Adaptive Biotechnologies Corporation	5,140	-0.26	-0.30	-1.23	Adaptive Biotechnologies EPS beats by $0.02, beats on revenue [8/10/2020 4:12 PM]	37.85	0.25 (0.66%)	38.07	0.47 (1.25%)	15.19 - 55.12	922,257	754,653	22,110

12-05-2020	AH	4:05 PM ET (May 12)	ADPT	Adaptive Biotechnologies Corporation	4,570	-0.25	-0.22	0.00	Adaptive Biotechnologies EPS misses by $0.04, misses on revenue [5/12/2020 4:06 PM]	35.57	-2.49 (-6.54%)	35.45	-0.12 (-0.34%)	15.19 - 55.12	1,903,460	942,753	31,480